TREOS THERAPEUTICS Alternatives & Competitors
12 companies similar to TREOS THERAPEUTICS — Changing the paradigm of active cancer immunotherapy development
Companies similar to TREOS THERAPEUTICS
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Bicara Therapeutics
Pioneering bifunctional antibodies for targeted tumor modulation
Boston, United States
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
Rival Readout
Competing with TREOS THERAPEUTICS? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
Houston, United States
Sensei Bio
We follow the immune system’s teachings to discover new treatments that inspire the body t...
Rockville, United States
Lytix Biopharma
A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...
Oslo, Norway
NexImmune, Inc.
NexImmune, Directing T cell function to restore natural immunity
Gaithersburg, United Stat...
NEOGAP Therapeutics AB
Science for cure.
Stockholm, Sweden
GenVivo, Inc.
We are a clinical stage company with an off-the-shelf, vector-based platform, for immunoth...
San Marino, United States
Epitopea
Exploiting a new class of tumour specific antigens for cancer therapy
Montreal, Canada
OXFORD VACMEDIX UK LIMITED
Developing therapeutic cancer vaccines using ROP technology
Oxford, United Kingdom
About TREOS THERAPEUTICS
TREOS BIO, founded in 2013, is a biotechnology company headquartered in the United Kingdom. The company is at the forefront of developing next-generation off-the-shelf peptide cancer vaccines designed to be effective across broad patient populations. TREOS BIO leverages a proprietary computational technology aimed at t...
development of off-the-shelf peptide immunotherapies, clinical trials for cancer treatments, biomarker identification for patient responsiveness
cancer patients, healthcare providers, oncologists, biotech investors
Cancer Immunotherapy, Peptide Vaccines, Computational Technology, Clinical Stage Company, Immuno-oncology, Patient Heterogeneity, Tumor Heterogeneity, Proprietary Peptides, Scalable Production, Diagnostic Tests, Computational Immunology, Predictive Technology, In Silico Design, Targeted Immunotherapies, Broad Patient Populations
B2B, B2D
Product Sales, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around TREOS THERAPEUTICS: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at TREOS THERAPEUTICS on 21 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
